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Abstract
Suppose we have a Bayesian model which combines evidence from several differ-
ent sources. We want to know which model parameters most affect the estimate or
decision from the model, or which of the parameter uncertainties drive the decision
uncertainty. Furthermore we want to prioritise what further data should be collected.
These questions can be addressed by Value of Information (VoI) analysis, in which
we estimate expected reductions in loss from learning specific parameters or collect-
ing data of a given design. We describe the theory and practice of VoI for Bayesian
evidence synthesis, using and extending ideas from health economics, computer mod-
elling and Bayesian design. The methods are general to a range of decision problems
including point estimation and choices between discrete actions. We apply them to
a model for estimating prevalence of HIV infection, combining indirect information
from several surveys, registers and expert beliefs. This analysis shows which parame-
ters contribute most of the uncertainty about each prevalence estimate, and provides
the expected improvements in precision from collecting specific amounts of additional
data.
Keywords: decision theory, research prioritisation, uncertainty
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1 Introduction
Bayesian modelling is a natural paradigm for decision making, in the presence of uncer-
tainty, based on multiple sources of evidence. However, as more data sources, parameters
and assumptions are built into a model, it becomes harder to see the influence of each input
or assumption. The modelling process should involve an investigation of where the weak
parts of the model are, to identify which uncertainties in the model inputs contribute most
to the uncertainty in the final result or decision (sensitivity analysis). We might then want
to assess and compare the potential value of obtaining datasets of specific designs or sizes
to strengthen different parts of the model. Furthermore, we may want to formally trade
off the costs of sampling with the resulting expected improvement to decision making.
Annual estimation of HIV prevalence in the United Kingdom has, for several years,
been based on a Bayesian synthesis of evidence from various surveillance systems and other
surveys (Goubar et al., 2008; Presanis et al., 2010; De Angelis et al., 2014; Kirwan et al.,
2016). This is an example of a class of problems called multiparameter evidence synthesis
(e.g. Ades and Sutton, 2006), where the quantities of interest are not directly observable,
but can be inferred from multiple indirect data sources linked through a network of model
assumptions that can be expressed as a directed acyclic graph. Markov Chain Monte Carlo
is typically required to estimate the posterior. The model is typically used to inform health
policies, and in this context it is important to be able to assess sensitivity to uncertain
model inputs and to indicate how the model could be strengthened with further data.
These dual aims can be achieved with value of information (VoI) analysis, a decision-
theoretic framework based on expected reductions in loss from future information. The
concepts of VoI were first set out in detail by Raiffa and Schlaifer (1961), while Parmi-
giani and Inoue (2009) give a more recent overview. The expected value of partial perfect
information (EVPPI) is the expected reduction in loss if the exact value of a particular
parameter or parameters θ0 were learnt, also interpreted as the amount of decision uncer-
tainty that is due to θ0. The expected value of sample information (EVSI) is the expected
reduction in loss from a study of a specific design. These concepts have been applied in
various forms in three distinct areas: health economics, computer modelling and Bayesian
design.
In health economic modelling, there is a large literature on calculation and application
of VoI, see, e.g. Felli and Hazen (1998); Willan and Pinto (2005); Claxton and Sculpher
(2006); Welton et al. (2008). The model output in this case is the expected net benefit
of each alternative policy, a known deterministic function g(θ) of uncertain inputs θ, and
the decision problem is the choice of policy that minimises g(θ). In computer modelling,
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see, e.g. Oakley and O’Hagan (2004) and Saltelli et al. (2004), the influence of a particular
element θ0 of θ is calculated as the expected reduction in var(g(θ)), if we were to learn θ0
exactly. This is equivalent to the EVPPI for θ0 under a decision problem defined as point
estimation of g(θ) with quadratic loss (Oakley and O’Hagan, 2004). The decision-theoretic
view of Bayesian experimental design also has a long history, see, e.g. Lindley (1956);
Bernardo and Smith (1994); Chaloner and Verdinelli (1995); Berger (2013), and a recent
review of the computational challenges by Ryan et al. (2016).
However, the current tools in any one of these three areas cannot be applied directly
to multiparameter evidence synthesis. For example, it is not always feasible or desirable
to make a discrete decision with a quantifiable loss, as in health economic modelling, as
often the aim of an evidence synthesis is simply to estimate one or more quantities. For
a scalar quantity of interest, we might then define the “loss” as the posterior variance of
this quantity, as in Oakley and O’Hagan (2004). In computer modelling, however, tools
to estimate the expected value of a proposed study to learn a particular θ0 more precisely
have not been developed, and it is not clear what an appropriate loss for a vector of
model outputs would be. Challenges also arise with computation. Current methods for
computing the expected variance reduction in the computer modelling field (Sobol’, 2001;
Saltelli et al., 2004) assume the output is a known function g(θ) of the inputs, therefore
do not apply in multiparameter evidence synthesis, where MCMC is required to obtain
the output. For Bayesian design, Ryan et al. (2016) reviewed methods where evaluating
the expected utility of a design (equivalent to the EVSI) is relatively inexpensive, so that
maximising the utility over a complex design space is feasible. However, this can again be
difficult with MCMC. Given a sample from the posterior p(θ|x), potential future datasets y
under a specific design can be simulated cheaply from the posterior predictive distribution,
but then to obtain the expected utility, it is required to repeatedly update the posterior
p(θ|x,y) for different y, which is only feasible with Monte Carlo for smaller problems (e.g.
Han and Chaloner, 2004).
We describe a VoI framework for sensitivity analysis and research design in evidence
syntheses based on graphical models, using and extending methods from health economics,
computer modelling and Bayesian design. This is a broader class of models than those
typically used in health economics or computer modelling, since the model “output” is
not necessarily a known function of the inputs, but depends on the model parameters θ
and observed data x through a network of statistical models or deterministic functions,
potentially with hierarchical relationships. We apply VoI methods to the part of the HIV
prevalence estimation model that estimates prevalence in men who have sex with men
(MSM), in London. Here the decision problem is point estimation of a single scalar or
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a vector of parameters. We use ideas from Bayesian design to choose appropriate loss
functions in this context. We also show how methods of computing EVPPI (Strong et al.,
2014) and EVSI (Strong et al., 2015) for finite choices in health economics, based on
fitting a non-parametric regression to a sample from the posterior, can be generalised to a
broader class of decision problems, including point estimation. The method for computing
EVSI enables the expected utility over all potential y to be estimated cheaply without an
additional level of simulation, assuming only that the information provided by y can be
represented as a low-dimensional sufficient statistic T (y).
In Section 2 we describe the general multiparameter evidence synthesis model, and de-
fine the expected value of information under different decision problems and loss functions,
and in Section 3 we present methods to compute them. In Section 4 we describe the model
for HIV prevalence estimation, and Section 5 we use VoI to identify the areas of greatest
uncertainty in this model and show where collecting specific data would improve the preci-
sion of the estimates of various subgroup-specific prevalences. Finally we discuss potential
extensions to the methods and application and the associated challenges.
2 Theory and methods
2.1 Bayesian graphical modelling for evidence synthesis
In our motivating applications, the general model can be represented as a directed acyclic
graph (Figure 1) in the standard way, see, e.g. Lauritzen (1996). Nodes in the graph may
represent scalar or vector quantities. A set of datasets x = {x1, . . . , xn} is observed, most
generally from n different sources. These data are assumed to arise from statistical models
with parameters µ1, . . . , µn respectively, collectively denoted µ. The “founder nodes” of the
graph are denoted φ = (φ1, . . . , φp) and given a joint prior distribution φ ∼ p(.) which may
also include substantive information. The full set of unknowns is denoted θ. Most simply,
the µ could equal the φ or be related to the φ through deterministic functions, so that
θ = φ. More generally, some of the relationships in the graph could be stochastic, defining a
hierarchical model, where the µ themselves arise from a distribution with parameters given
by the φ or descendants of φ. θ would then comprise φ and the stochastic descendants of
φ such as random effects.
We further denote α as an intermediate node in the graph, the model “output”, which
is used for decision-making. This could be any unknown quantity, including one of the µ
or φ, a function of these, or a prediction of new data. We may also be in a position to
collect additional data, either from the same source as one of the existing datasets (e.g. y1
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Figure 1: Directed acyclic graph for Bayesian evidence synthesis
in Figure 1), or from a new source informing a parameter µn+1 on which no direct data
(y2) were available.
This DAG (Figure 1) is a generalisation of the typical structure (Figure 2) used in
computer modelling (Oakley and O’Hagan, 2004) where the output α is a known (usually
complicated) deterministic function of uncertain model inputs φ, which are given substan-
tive priors that may be derived separately from data.
2.2 Expected value of information: definitions
In a general decision-theoretic framework, the purpose of the model is to choose a de-
cision or action d from a space of possible decisions D, to minimise an expected loss
Eθ(L(d,θ)), with the expectation taken with respect to the posterior distribution of θ.
Let α = α(θ) be the minimal subset or function of θ necessary to make the decision, so
that Eθ(L(d,θ)) = Eα(L(d,θ)), ∀d ∈ D. For example, the purpose could be the choice
of decision d among a finite set D = {1, . . . , D} expected to minimise a loss defined as a
function of the parameters, so that α would be a vector with D components αd = fd(θ)
say, with L(d,θ) = αd. This is the typical situation in health policy decisions (e.g. Claxton
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Figure 2: Graph representing a known deterministic model
and Sculpher, 2006), where a treatment d is chosen to maximise a measure of utility such
as expected quality-adjusted survival. Alternatively, as in our examples, the decision could
simply be the choice of a point estimate αˆ of some parameter α, in which case the decision
space D is the (typically continuous) support of α (see §2.3).
For general decision problems, let d∗ = arg mindEθ(L(d,θ)) be the optimal decision un-
der current knowledge about θ, represented by the posterior distribution p(θ|x). Suppose
now we are in a position to collect new information. Let d∗y be the optimal decision given
further knowledge of a quantity y (either parameters or potential data) that informs α, so
that the updated posterior would be p(θ|x,y).
1. The expected value of perfect information (EVPI) is the expected loss of the decision
d∗ under current information, minus the expected loss for the decision d∗α we would
make if we knew the true α (Raiffa and Schlaifer, 1961).
Eθ(L(d
∗,θ))− Eθ(L(d∗α,θ))
Since additional information is always expected to reduce the expected loss of the
optimal decision (Parmigiani and Inoue, 2009), the EVPI is an upper bound on the
expected gains from any new information.
2. The expected value of partial perfect information (EVPPI) for a particular (scalar or
vector) parameter φ is the expected reduction in loss if φ were to be known precisely:
EV PPI(φ) = Eθ(L(d
∗,θ))− Eφ[Eθ|φ(L(d∗φ,θ))] (1)
where d∗φ is the optimal decision if φ were known. This is an upper bound on the
potential value of data y which inform only φ. In a graphical model, this means data
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y that are conditionally independent of θ given φ, for example y = y1 and φ = µ1
in Figure 1.
3. The expected value of sample information EV SI(y) is the reduction in loss we would
expect from collecting an additional dataset y of a specific design.
EV SI(y) = Eθ(L(d
∗,θ))− Ey
[
Eθ|y(L(d∗y,θ)
]
(2)
The inner expectation is now with respect to the updated posterior distribution of
θ|y, after learning y as well as the existing data x, or “preposterior” (Berger, 2013).
If we can express the costs C(y) of obtaining y using the same loss metric, we can
further define the expected net benefit of sampling as EV SI(y)−C(y), and typically
seek the sample size that maximises this (Parmigiani and Inoue, 2009).
2.3 Value of information in different decision problems
Finite-action decisions For a choice of d among a finite set {1, . . . , D} with loss L(d,θ) =
αd andα = {α1, . . . , αd, . . . , αD}, the expected loss with current information is mind{Eα(αd)},
so (Raiffa and Schlaifer, 1961)
EV PI = min
d
{Eα(αd)} − Eα min
d
{αd}
EV PPI(φ) = min
d
{Eα(αd)} − Eφ min
d
{Eθ|φ(αd)}
EV SI(y) = min
d
{Eα(αd)} − Ey min
d
{Eα|y(αd)}
Point estimation of a parameter When the decision is the choice of a point estimate
αˆ of a vector of parameters α, with quadratic loss
L(αˆ,α) = (αˆ−α)TH(αˆ−α) (3)
for a symmetric, positive-definite H, the optimal estimate with current information is the
posterior mean, αˆ = Eα(α). For a scalar α = α and H = 1, the expected loss is var(α)
under current information and zero under perfect information, so that EV PI = var(α) and
EV PPI(φ) = var(α)− Eφ
[
varα|φ(α|φ)
]
(4)
EV SI(y) = var(α)− Ey
[
varα|y(α|y)
]
(5)
the expected reduction in variance given new information. Expression (4) is used by Oakley
and O’Hagan (2004) and Saltelli et al. (2004) as a measure of sensitivity of the output of
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a deterministic model α = g(φ, . . .) to an uncertain input φ, termed the main effect of φ,
but this has not been extended to the EVSI of a potential dataset y in this context.
Alternatively, an absolute error loss (Bernardo and Smith, 1994) gives αˆ as the posterior
median and value measures based on the mean absolute deviation.
Point estimation of multiple parameters The purpose of a multiparameter evidence
synthesis of the form in Figure 1 is typically to estimate several correlated parameters of
interest, comprising a vector α, say. Most simply, we could conduct independent value
of information analyses for each component of α. In more formal decision analyses we
may want a scalar loss for the overall vector α. There are various alternatives based on
generalisations v(α) of the variance, which can be used instead of the scalar variance var(α)
in equations (4)–(5) to define the expected value of information. These have been applied
in the context of Bayesian study design, and we show how they can also be used for the
EVPPI and EVSI in evidence synthesis models.
1. If H = ccT in the quadratic loss (3), for some vector of weights c, then the expected
loss is v(α) = cT cov(α)c = var(cTα), corresponding to optimal estimation of the
weighted sum of the parameters, cTα. For example, when the elements αs of α
are weighted equally, the goal is to minimise the sum of all elements (r, s) of the
covariance matrix, v(α) =
∑
r,s cov(α)r,s, or, if the αs are also independent of each
other, v(α) = tr(cov(α)) =
∑
s var(αs). The same absolute reductions in variance
for different components of α would then be valued equally. More generally, if c
is given a prior, then loss (3) also arises (see Chaloner and Verdinelli (1995) and
references therein). Designs that minimise (3) are Bayesian analogues of classical
A-optimal designs. See also Lamboni et al. (2011) for similar measures of sensitivity
for multivariate outputs in deterministic computer models.
2. A Bayesian D-optimal design, on the other hand, minimises the determinant v(α) =
det(cov(α)) (Chaloner and Verdinelli, 1995; Ryan et al., 2016). This simplifies to the
product of the var(αs) when the αs are independent and equally-weighted. Equiva-
lently, a standardised version det(cov(α))1/S, where S is the number of components
of α, represents a geometric average variance of the αs, adjusted for their covariance.
Here the same relative reductions in variance for different components of α would
then be valued equally, which would be more appropriate when the output of interest
α comprises quantities on very different scales and/or with different interpretations.
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3 Computation of value of information
3.1 Partial perfect information
Computation of the EVPPI in general is not straightforward. Given a sample from the
posterior distribution, the first term in (1) can be calculated by a Monte Carlo mean. The
double expectation in the second term is more challenging. Strong et al. (2014) presented a
method for estimating the EVPPI which avoids an expensive nested Monte Carlo procedure.
However this only applied to finite-choice decision problems. We extend the scope of this
method to more general problems, including point estimation. Suppose that, given a state
of knowledge about α represented by a distribution ψ(.), the expected loss under the
optimal decision is a known function h of the mean of α under that distribution.
Eψ(L(d
∗
ψ,θ)) = h(Eψ(α)). (6)
If ψ(.) is the current posterior, this is h(Eα(α)), and if we were to learn the value of φ,
the expected loss would be h(Eα|φ(α|φ)). We can estimate Eα|φ(α|φ) by expressing
α = Eα|φ(α|φ) +  = g(φ) +  (7)
where  is an error term with mean zero. Then using a Monte Carlo sample of (α(k),φ(k)) :
k = 1, . . . , K, we estimate g(φ) by regression of α on φ. If φ comprises p parameters that
could be learnt simultaneously, the regression will have p predictors. Since the functional
form of g() will not be known in general, nonparametric regression methods are preferred.
This produces a fitted value gˆ(φ(k)) for each k.
Then the second term in (1) is estimated by a Monte Carlo mean
Eφ[Eθ|φ(L(d∗φ,θ))] = Eφ[h(Eα|φ(α|φ))] ≈
1
K
K∑
k=1
h(gˆ(φ(k))).
Strong et al. (2014) only presented this method for finite choices, where α is a vector and
h(E(α)) = maxd{E(αd)}. Then a separate gd() is estimated to relate each αd to φ, and
Eφ[Eθ|φ(L(d∗φ,θ))] ≈
1
K
K∑
k=1
max
d
{gˆd(φ(k))},
Our more general formulation of this algorithm, which expresses the optimal loss as h(E(α)),
can be used for point estimation problems. For estimation of a scalar α with quadratic loss,
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h(Eα(α)) = E[(α − Eα(α))2] = var(α). We estimate var(α|φ(k)) by the squared residual
(α − gˆ(φ(k)))2, substitute this for h(gˆ(φ(k))) and estimate Eφ
[
varα|φ(α|φ)
]
as the mean,
over k, of the squared residuals. Equivalently we can estimate var(θ)−Eφ
[
varα|φ(α|φ)
]
=
varφ(Eα|φ(α|φ)) as the variance, over k, of the fitted values. Similarly, for vector α and
loss functions based on cov(α), we can fit regressions to get the marginal mean for each
component αd, and calculate the empirical covariance matrix of the residuals.
Several methods of nonparametric regression have been suggested. For small p, Strong
et al. (2014) used generalized additive models, with tensor products of spline smoothers to
represent interactions between different components of φ. Where φ included about p = 5
or more components, Gaussian process regression was recommended as a more efficient
way of modelling interactions, though the resulting matrix computations rapidly become
impractical as the MCMC sample size K increases. Heath et al. (2016) developed an
integrated nested Laplace approximation for fitting Gaussian processes more efficiently in
this context where p >= 2. For the application in Section 4 (with K = 150000, p ≤ 3),
we have found multivariate adaptive regression splines (Friedman, 1991) via the earth R
package (Milborrow, 2011) to be more efficient. Standard errors for the EVPPI estimates
can be calculated in general by simulating from the asymptotic normal distribution of the
regression coefficients (Mandel, 2013).
For expected losses which are functions of the median or other quantiles, such as absolute
error loss, a similar method based on nonparametric quantile regression could be devised.
3.2 Sample information
The regression method above can also be used to estimate the expected value of sample
information EV SI(y). Strong et al. (2015) described the method for finite decision prob-
lems. Again we generalize this to any problem satisfying condition (6), including point
estimation. The method requires that the information provided by the data y can be ex-
pressed as a low-dimensional sufficient statistic T (y), so that Eα|y(α|y) = Eα|y(α|T (y)).
This could be a point estimator of the parameter µ (as in Figure 1) that y gives direct
information on. As in (7), we can write
α = Eα|y(α|T (y)) +  = g(T (y)) + 
and estimate g() using a regression fitted to a Monte Carlo sample of (α(k), T (y(k))) : k =
1, . . . , K, where y(k) are drawn from their posterior predictive distribution. Then the fitted
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values gˆ(T (y(k))) enable the double expectation to be estimated as
Ey[Eθ|y(L(d∗y,θ))] = Ey[h(Eα|y(α|y))] ≈
1
K
K∑
k=1
h(gˆ(T (y(k)))).
Then, for example, for point estimation with quadratic loss, this is the estimated residual
variance from the regression, as in Section 3.1.
4 HIV prevalence estimation model
We consider the sub-model of the full HIV burden model (De Angelis et al., 2014; Kirwan
et al., 2016) that estimates HIV prevalence in men who have sex with men (MSM), in
London. We examine two subgroups of MSM: those who have attended a genitourinary
medicine (GUM) clinic in the past year (GMSM) and those who have not (NGMSM),
denoting the proportion of all men who are in these subgroups by ρG and ρN respectively.
For each group g ∈ (G,N), we aim to estimate simultaneously these subgroup proportions
ρg, prevalence of HIV in this group pig and the proportion of infections that are diagnosed,
δg. Given these parameters, further important quantities are easily derived: the prevalence
of diagnosed (pigδg = (piδ)g) and undiagnosed (pig(1 − δg) = (piδ)g) infection; and the
numbers of MSM living with diagnosed (µDg = µpopρg(piδ)g) and undiagnosed (µUg =
µpopρg(piδ)g) infection, where µpop is the number of men (MSM and non-MSM) living in
London. Parts of the model refer to a third subgroup, previous MSM (PMSM), men who
no longer have sex with men, but the prevalence among this group is much lower, and we
do not describe this part in detail.
We construct a Bayesian model to link these quantities with the available evidence pro-
vided by various routinely-collected and survey datasets as well as expert belief. Figure 3
shows a directed acyclic graph representing this model, in the form of Figure 1, distinguish-
ing founder nodes, observed data, and outputs of interest. The following sections explain
in detail the quantities and relationships illustrated in Figure 3. All data and estimates
refer to the year 2012 (unless indicated) and the Greater London area.
4.1 Subgroup membership
The total male population of London, µpop, is informed by published data ypop (Office for
National Statistics, 2012), assumed to be a Poisson count: ypop ∼ Po(µpop). The esti-
mated number of people in each group g is therefore rg = ρgµpop, where we assume a
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Figure 3: Directed acyclic graph for HIV prevalence estimation model.
prior log(µpop) ∼ N(0, 10002). Estimates of the subgroup proportions ρg are informed by
data from the National Survey of Sexual Attitudes and Lifestyles (Mercer et al., 2013):
yG, yN , yP , out of yNAT = 824 men, which we assume to come from a multinomial dis-
tribution with probabilities ρG, ρN , ρP given a uniform Dirichlet prior. P here refers to
the PMSM subgroup, with ρP being the corresponding proportion of men in the group.
Thus the expected number of people with HIV (diagnosed or undiagnosed) in group g is
µg = pigrg.
4.2 Registry of diagnosed infections and diagnosed prevalence
Individuals diagnosed with HIV and accessing care in the UK are reported to the SOPHID
registry (Surveillance of Prevalent HIV Infections Diagnosed) (Kirwan et al., 2016). From
SOPHID we obtain the reported number of HIV diagnoses for MSM, yM ∼ Po(µM). We
assume a small reporting bias of unknown direction, through log(µM) = aS+log(µD) where
exp(aS) ∼ N(1, 0.0182), giving a prior 90% interval of about (−3%, 3%) for the adjustment
to the number of MSM HIV diagnoses µM . After this adjustment, µD = µDG +µDN +µDP
is the expected number of diagnoses among MSM, summed from the expected numbers of
diagnoses among GMSM, NGMSM and PMSM respectively. The following sections explain
where µDG, µDN come from; µDP is modelled using similar techniques.
Since SOPHID does not record GUM clinic attendance, to strengthen the evidence on
diagnosed prevalence in GMSM we include data from the HIV and AIDS New Diagnoses
Database (HANDD) (Kirwan et al., 2016), recording how many of the yM prevalent diag-
nosed MSM were newly diagnosed in 2012 and reported to have been diagnosed initially in
a GUM clinic. These new diagnoses, denoted yH , are modelled as yH ∼ Bin(yM , pH), where
pH is assumed to be a lower bound for the proportion of prevalent diagnosed MSM who
have attended a GUM clinic in 2012. This bound is expressed through pH = aHµDG/µD,
where aH ∼ U(0, 1) is the unknown probability that a prevalent diagnosed MSM who
has attended a GUM clinic in 2012 was newly diagnosed that year. yH therefore gives us
additional indirect information on µDG, the number of prevalent diagnosed GMSM.
The number of diagnosed infections is related to the total number of infections in each
group g = G,N as µDg = δgµg. The proportion of infections that are diagnosed δg is
not known, but given our inferences about the undiagnosed prevalence (piδ)g = pig(1− δg)
(explained in the subsequent sections), we can exploit the implicit constraint 1−δg > (piδ)g.
Therefore we define δg = aδg(1− (piδ)g), with aδg ∼ U(0, 1), and the diagnosed prevalence
(piδ)g = pigδg in each group follows.
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4.3 Undiagnosed prevalence among GMSM
Information about undiagnosed infections in GMSM is obtained from GUMCAD (Geni-
tourinary Medicine Clinic Activity Dataset) (Kirwan et al., 2016) a registry of attendance
episodes in GUM clinics. HIV tests are offered routinely to previously-undiagnosed pa-
tients. Thus we have a sequence of observations gi, representing firstly the number of
GUM clinic visits (g1 = 35121) and then the number of these where the patient has no
previous HIV diagnosis (g2), an HIV test is offered (g3), an HIV test is accepted (g4),
or a new HIV diagnosis is made (g5). For i = 2, . . . , 5, gi ∼ Bin(gi−1, γi−1), with priors
γ1, γ2, γ3 ∼ U(0, 1) and γ4 ∼ U(0, 0.15) (see below). An HIV infection may therefore re-
main undiagnosed if either a test is not offered or the patient opts out of testing. We can
then decompose the prevalence of undiagnosed infection (piδ)G into “unoffered” pi
(UN) and
“opt-out” pi(OP ) components.
(piδ)G = pi
(UN) + pi(OP ). (8)
Both of those require strong prior assumptions to estimate, which will later be relaxed in
a sensitivity analysis (§4.5). Firstly, the prevalence of infection that remains undiagnosed
due to an unoffered test is
pi(UN) = γ1(1− γ2)p(UN)
where γ1(1−γ2) is the proportion of clinic attenders that are undiagnosed but not offered a
test, and p(UN) is the probability that a test would be positive for these people. We assume
the prevalence in this group is between 0.5 and 1.5 times the prevalence in people actually
tested, and logit(p(UN)) = logit(γ4) + a
(UN), with a(UN) ∼ U(log(0.5), log(1.5))
Secondly, the prevalence of infection remaining undiagnosed due to refusing a test is
pi(OP ) = γ1γ2(1− γ3)(γ4 + a(EX))
γ1γ2(1 − γ3) is the proportion of clinic attenders that are undiagnosed and offered a test
but opt out. We assume this group has an underlying HIV prevalence higher than those
given tests, but not more than 15%, so that the excess prevalence in this group is a(EX) =
a(OP )(0.15− γ4), where a(OP ) ∼ U(0, 1), and the prior on γ4 is truncated above at 0.15.
A small amount of additional evidence on (piδ)G is available from another dataset, GUM
Anon, a convenience survey of men not previously diagnosed with HIV who had attended
a GUM clinic in the previous year. This gives direct information about the prevalence of
HIV among previously undiagnosed GMSM,
pi(GA) = ((piδ)G + pi
(GD))/γ1, (9)
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where pi(GD) =
∏4
1 γr is the prevalence of newly-diagnosed infection among clinic attenders.
The data in GUM Anon are g(A) ∼ Bin(g(AN), pi(GA)), where g(AN) = 85.
4.4 Undiagnosed prevalence among NGMSM
To inform undiagnosed HIV prevalence in NGMSM, we use data from the Gay Men’s Sexual
Health Survey (GMSHS) (Aghaizu et al., 2016), based on face-to-face interviews in selected
venues where participants were offered anonymous HIV tests. While this group is likely
to have a higher HIV prevalence than the general population, we assume that the relative
odds of having HIV between NGMSM and GMSM is the same as in the general population.
The GMSHS data provide the numbers y
(GM)
g out of n
(GM)
g previously-undiagnosed people
in group g who tested positive for HIV (493 GMSM and 452 NGMSM) so that y
(GM)
g ∼
Bin(n
(GM)
g , p
(GM)
g ), with p
(GM)
g ∼ U(0, 1). Defining the odds o(p) = p/(1−p), we apply the
resulting odds ratio or(GM) = o(p
(GM)
N )/o(p
(GM)
G ) to the baseline estimated from GUMCAD
(Section 4.3), giving o((piδ)N) = o((piδ)G)or
(GM).
4.5 Alternative assumptions
The results presented in section 5 are for the above model assumptions, unless specified
otherwise. Two alternative assumptions are also explored.
(a) Undiagnosed prevalence from GUM Anon only To avoid the strong prior as-
sumptions on prevalence among those not offered a test or refusing a test, which are
necessary to use the GUMCAD data to infer (piδ)g, we could infer (piδ)g from GUM
Anon alone. To construct this model, we replace equation (8) by a U(0, 1) prior on
(piδ)g, although the GUMCAD data are still used to estimate the parameters pi
(GD)
and γ1 relating the prevalence in GUM Anon to (piδ)g.
(b) GUMCAD also informs diagnosed prevalence Instead of being inferred indirectly
though the graph, the diagnosed prevalence can be modelled directly as
(piδ)G = (1− γ1) + γ1γ2γ3γ4, (10)
where 1−γ1 is the probability of a previous diagnosis, and γ1γ2γ3γ4 is the probability
of newly-diagnosed infection, in GUMCAD. This is not done in the base case due
to concerns about inconsistencies in reporting of diagnoses between GUMCAD and
SOPHID/HANDD.
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5 Value of information in HIV prevalence model
The model outputs of interest (as in Figures 1,3) are α =((piδ)G, (piδ)N , (piδ)G, (piδ)N ,
µDG, µDN , µUG, µUN , µ), the diagnosed and undiagnosed prevalences among both GMSM
and NGMSM, and the corresponding absolute numbers of people living with HIV/AIDS (or
“case-counts”), and the total number of MSM with HIV/AIDS µ = µDG+µDN+µUG+µUN .
Samples from the posterior distributions are generated using Hamiltonian Monte Carlo
methods in the Stan software (Stan Development Team, 2016). These are illustrated in
Figure 8 along with the overall prevalence pig = (piδ)g + (piδ)g in each group g, and each of
these quantities summed over the two groups g. The estimates of diagnosed prevalence in
all MSM (top panel) are reasonably precise, while the corresponding estimates for NGMSM
and GMSM are more uncertain. Estimates of undiagnosed prevalence are lower and more
precise. Full results under the two alternative assumptions are presented in the appendix.
5.1 Partial perfect information (EVPPI) for single outputs
Defining the decision problem as point estimation of α with quadratic loss, we use EVPPI
formula (4) to determine which parameters φ contribute most to the uncertainty about
each component of α, thus which φ may be worth learning more precisely. We will take
φ to include the founder nodes of the graph illustrated in Figure 3. Since they are related
to the α through a network of deterministic functions, perfect knowledge of these implies
perfect knowledge of α. Each of the φ are either directly informed by data or given a
substantive prior distribution based on belief. In the former case, EVPPI measures the
maximum potential value of collecting more data from the same source. In the latter case,
it will not necessarily be feasible to collect data to improve the precision of the belief, but
EVPPI is still useful as a measure of how much of the uncertainty in α is explained by the
uncertainty in the parameter.
The results are presented in Figure 10 as a grid whose r, s entry is colored according
to EV PPIαs(φr)/var(αs), the proportion of variance in αs which would be reduced if we
learnt φr. The lighter cells correspond to φr with greater EVPPI. Standard errors in these
and all following EVPPI and EVSI estimates, arising from uncertainty in the coefficients
of the regression (7), were negligible, at less than 1% of the EVPPI or EVSI estimates.
The parameters aδG and aδN , governing the proportions of HIV infections in each group
that are diagnosed in each of the two groups, and the probability aH that a GMSM is newly
diagnosed in a GUM clinic, explain most of the uncertainty in the diagnosed prevalences
(piδ)G, (piδ)N and the corresponding numbers of people diagnosed µDG, µDN . Direct data
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Figure 5: Expected value of partial perfect information in the HIV prevalence model.
on any of these parameters would be difficult to obtain. However, if we were willing to
make the assumption in (10), the estimates of diagnosed prevalence would become more
precise, for example the posterior median (SD) of (piδ)G would change from 0.06 (0.13)
to 0.051 (0.001), though the extent of uncertainty around (piδ)N , µDN would not change
substantively.
For the undiagnosed prevalences (piδ)G, (piδ)N and undiagnosed case count µUG, Fig-
ure 10 shows that more GUM-Anon data (via pi(GA)), more GMSHS data (via or(GM)) and
more NATSAL data (via ρUG) respectively would give the greatest uncertainty reductions.
These outcomes, however, are already precisely estimated in absolute terms (Figure 8). The
number of NGMSM µUN with undiagnosed HIV is more uncertain, with 95% CI (277,1446),
and more GMSHS data would be potentially valuable to reduce this uncertainty.
If (piδ)G were informed only from the 85 people observed in GUM Anon (alternative
assumption (a)), the estimates of undiagnosed prevalence or case counts become extremely
uncertain, for example, var(µUN) increases from 304
2 to 28592. We could reduce this
uncertainty by collecting more GUM Anon data — since EV PPIµUN (pi
(GA)) is p = 62% of
var(µUN), more GUM Anon data could reduce var(µUN) to a minimum of 2859
2(1− p) =
17702 (note that the square root of the expected variance after learning data is not the
same as the expected standard deviation).
5.2 Partial perfect information for multiple outputs
Staying with alternative assumption (a), suppose we wish to calculate the maximum po-
tential value of extra GUM Anon data for jointly reducing the uncertainty about the
number of GMSM, NGMSM and PMSM with undiagnosed HIV, so that α is the vec-
tor (µUG, µUN , µUP ). As described in Section 2.3, we could simply calculate the standard
EVPPI based on a scalar output α redefined as their sum, µU = µUG + µUN + µUP , the
total number of MSM with undiagnosed HIV, whose posterior median is 5164 (SD 3271).
This would ensure that any data expected to reduce the variance of any of these three
outputs by the same (additive) amount would be valued equally. From this, we find that
extra GUM Anon data would be expected to reduce var(µU) from 3271
2 to a minimum of
18032. Since µU is dominated by NGMSM (posterior median of µUN is 4190), this is mostly
explained by an expected reduction in var(µUN) from 2859
2 to a minimum of 17702.
Alternatively, suppose both the prevalences and the case counts are of interest, for
example in NGMSM, so that α = ((piδ)N , µUN). Since these two components are on very
different scales, the Bayesian “D-optimality” criterion v(α) = det(cov(α)) would be a
preferable measure of overall expected loss due to uncertainty. We use this criterion to
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compare the maximum expected value of extra GUM Anon data and extra GMSHS data,
which combine to estimate the outcomes for NGMSM as described in Section 4.4. The
EVPPI is interpreted as the expected reduction in the product of var((piδ)N) and var(µUN)
given by extra GUM Anon or GMSHS data, adjusted for their covariance. This is 421
and 132 respectively, favouring extra data from GUM Anon. Though in this example,
examining expected reductions in var((piδ)N) or var(µUN) separately would lead to the
same conclusion, since (piδ)N is defined as the proportion µUN/rN of NGMSM with HIV,
and GUM Anon and GMSHS are not informative about the number rN of NGMSM, thus
extra data informs µUN entirely through information on (piδ)N (or vice versa).
5.3 Sample information
We now estimate the expected value of data with specific sample sizes for improving the
precision of the estimated number of people µU with undiagnosed HIV. Using the GUMCAD
data and associated strong prior assumptions, the posterior median of µU is 804 (SD 323),
compared to 5164 (SD 3271) with this information excluded. We compare the value of
additional data from GUM Anon and additional data from GMSHS (on top of their original
sample sizes of 85 and 945 respectively) for reducing these posterior standard deviations.
The expected value of sample information (EVSI) is computed for a series of sample sizes
n using the method in Section 3.2. For GUM Anon (Section 4.3), the sufficient statistic T (y)
consists of the empirical HIV prevalence y/n from an additional survey y ∼ Bin(n, pi(GA)).
For GMSHS (Section 4.4), given a sample size n, y = (N
(GM)
G , Y
(GM)
G , Y
(GM)
N ), where N
(GM)
G
is the number of previously-undiagnosed MSM in the future sample of n who attend GUM
clinics (the equivalent of the observed n
(GM)
G = 493). Then Y
(GM)
G and Y
(GM)
N are the
numbers of men out of denominators N
(GM)
G and N
(GM)
N = n−N (GM)G (GMSM and NGMSM
respectively) who test positive for HIV, the equivalents of the observed y
(GM)
G = 20, y
(GM)
N =
492. We take T (y) = o(pˆ
(GM)
N (y))/o(pˆ
(GM)
G (y)), a point estimator of the odds ratio, where
pˆ
(GM)
G (y) is an estimator of the proportion of MSM in group g who have HIV. To avoid
zeros in the denominator o(pˆ
(GM)
G (y)), we use a Bayesian estimator pˆ
(GM)
G (y) = (Y
(GM)
G +
0.5)/(N
(GM)
G +1), the posterior mean of a binomial proportion under a Jeffreys Beta(0.5,0.5)
prior, rather than the empirical proportion Y
(GM)
G /N
(GM)
G .
Figure 6 shows var(µU)−EV SI(y), the expected variance remaining after data collec-
tion, under the two alternative assumptions. With the strong priors, µU is relatively well
informed, and extra data from GUM Anon at realistic sample sizes (1000 or less) would
not noticeably reduce var(µU). GMSHS data would be more valuable, through improving
20
the estimate of µUN , the more uncertain contributor to µU = µUG + µUN . 1000 extra
observations from GMSHS would be expected to reduce var(µU) from 323
2 to 2822.
Without the strong prior information, var(µU) = 3271
2 is substantially greater, and
µU is only directly informed by the 85 observations from GUM Anon. Extra data from
this source would be valuable, for example, another 500 observations would be expected to
reduce this variance to 21832. Relative to these improvements, GMSHS data of the same
size would be much less valuable. GMSHS data however would be expected to give around
the same absolute reductions in var(µU), whether or not the strong priors are included.
6 Summary and potential further work
We have presented tools to find the most influential sources of uncertainty in a multipa-
rameter evidence synthesis context and determine the expected value of extra data. We
generalized methods, previously only applied in deterministic models, to complex graphical
models, a class which also includes hierarchical models. We have shown how VoI methods
developed for formal finite-choice decision problems can be extended to deal with estima-
tion of single or multiple quantities. Therefore the same methods can be used for formal
decision problems based on graphical models, e.g. an HIV prevalence estimation model
such as ours could be used to compare strategies for HIV testing. This would allow the
optimal sample size of future data to be determined, through a health economic loss that
trades off the cost of data collection with the expected health benefits gained from extra
information that reduces the probability of choosing a sub-optimal policy.
In the HIV application, we found that structural assumptions, such as whether to
include a particular piece of information, were influential to both the parameter estimates
and the value of information. Such uncertainties might be parameterised (see, e.g. Strong
et al., 2012), for example a particular prior or dataset of uncertain relevance could be
discounted using an unknown weight (e.g. Neuenschwander et al., 2009). The EVPPI
of the extra parameter would then quantify this uncertainty in the context of all other
uncertainties, referred to as the “expected value of model improvement” by Strong and
Oakley (2014).
Note that VoI refers to the expected value of potential future information, which differs
from the observed value of a dataset xi currently included in the model. The latter could
be computed as the observed reduction in loss when the model is refitted without xi. This
could demonstrate the value of past data to the policymaker responsible for funding the
collection of future data of the same type. For surveys or longitudinal studies conducted at
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Figure 6: Expected value of sample information: value of additional data from GUM Anon
or GMSHS for reducing the variance of the total number of MSM with undiagnosed HIV,
µU = µUG +µUN . The x axis is on the log scale. The y axis is the variance, with the labels
as SD2.
regular intervals, VoI might be used to determine the expected value of future surveys or
follow-up, although a full analysis would require modelling the expected changes through
time in the quantities, such as disease prevalence or incidence, informed by the data.
While our method is broadly applicable, the details of computation for different de-
cision problems and loss functions will be different. We discussed finite-action decisions
and point estimation. A more general decision problem is to estimate the entire uncer-
tainty distribution of θ. The standard posterior p(θ|y) is then optimal under a log scoring
rule (Bernardo and Smith, 1994), and (following Lindley, 1956) standard Bayesian design
theory aims to maximise the information gain from new data y, which we can write as
EV SI(y) = Eθ(− log(p(θ))) + EyEθ|y{log(p(θ|y)). Under linear models (Chaloner and
Verdinelli, 1995), this is equivalent to minimising det(cov(θ)), but more generally this is
challenging to compute (Ryan et al., 2016).
Note that the VoI approach to sensitivity analysis is an example of the “global” ap-
proach, which examines the changes in model outputs given by varying parameters within
the ranges of their belief distributions. The “local” approach is based on examining the
posterior geometry resulting from small parameter perturbations around a base case, e.g.
Roos et al. (2015) assess the robustness of hierarchical models to prior assumptions in this
way. While the global approach is easier to interpret, as discussed by Oakley and O’Hagan
(2004) and Roos et al. (2015), it conditions on one particular prior specification, and pa-
rameterising all potential prior beliefs or structural assumptions would be impractical.
The regression method for VoI computation that we described requires only a MCMC
sample from the joint distribution of parameters of interest φ and outputs α. Addition-
ally for EVSI it requires that the information in the new data y can be condensed into
an analytic sufficient statistic T (y). Alternative methods which exploit particular analytic
structures of g(), where α is a known function g(φ), thus avoiding a regression approxi-
mation, were discussed by Madan et al. (2014) for EVPPI and and Ades et al. (2004) for
EVSI. Menzies (2016) also presented an importance resampling method for EVSI compu-
tation which needs only a single MCMC sample and not a sufficient statistic.
In conclusion, the consideration of future evidence requirements is an often-neglected
part of statistical analysis. The Value of Information methods we have presented provide a
practicable set of tools for achieving this aim in the context of Bayesian evidence synthesis.
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Figure 7: Posterior distributions of HIV prevalence (top) and numbers of MSM living with
HIV/AIDS (bottom), London 2012. Darkness within each strip proportional to poste-
rior density, with 95% credible intervals indicated. Alternative scenario (a): undiagnosed
prevalence from GUM Anon only
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Figure 8: Posterior distributions of HIV prevalence (top) and numbers of MSM living with
HIV/AIDS (bottom), London 2012. Darkness within each strip proportional to posterior
density, with 95% credible intervals indicated. Alternative scenario (b): GUMCAD also
informs diagnosed prevalence
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Figure 9: Expected value of partial perfect information in the HIV prevalence model.
Alternative scenario (a): undiagnosed prevalence from GUM Anon only
Prevalence from GUM Anon: pi(GA)
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Figure 10: Expected value of partial perfect information in the HIV prevalence model.
Base case analysis in paper. Alternative scenario (b): GUMCAD also informs diagnosed
prevalence
